Understanding insulin resistance and syndrome X

Patient Care

Volumn 30, Issue 11, 1996, Pages 198-211

  Garber, Alan J ^a   Gavin III, James R ^a   Goldstein, Barry J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842789893     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lindahl B, Asplund K, Hallmans G: High serum insulin, insulin resistance and their associations with cardiovascular risk factors: The northern Sweden MONICA population study. J Intern Med 1993;234:263-270.
2. Skott P, Vaag A, Bruun NE, et al: Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance. Diabetologia 1991;34:275-281.
3. Weir GC: Which comes first in non-insulin-dependent diabetes mellitus: Insulin resistance or beta-cell failure? Both come first, editorial. JAMA 1995;273:1878-1879.
4. Davies MJ, Gray IP: Impaired glucose tolerance. BMJ 1996;312:264-265.
5. Chiasson JL, Josse RG, Letter LA, et al: Can we prevent the development of non-insulin-dependent diabetes mellitus? Diabetes 1994;43(suppl 1):62A (abstract 199).
6. Mayer EJ, Newman B, Austin MA, et al: Genetic and environmental influences on insulin levels and the insulin resistance syndrome: An analysis of women twins. Am J Epidemiol 1996;143:323-332.
7. Stern MP: Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996;124:110-116.
8. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-381.
9. Godsland IF, Stevenson JC: Insulin resistance: Syndrome or tendency? Lancet 1995;346:100-103.
10. Davidson MB: Clinical implications of insulin resistance syndromes. Am J Med 1995;99:420-426.
11. Yamashita S, Nakamura T, Shimomura I, et al: Insulin resistance and body fat distribution. Diabetes Care 1996;19:287-291.
12. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
13. National Institute of Diabetes and Digestive and Kidney Diseases: Diabetes in America, Second Edition. Bethesda, Md, NIDDK, 1996.
14. Knowler WC, Narayan KMV, Hanson RL, et al: Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-488.
15. DeFronzo RA, Goodman AM, the Multicenter Metformin Study Group: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541-549.
16. Balfour JA, McTavish D: Acarbose: An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1993;46:1025-1054.
17. Tenkanen L, Manttari M, Manninen V: Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Circulation 1995; 92:1779-1785.
18. Goldstein BJ: Syndromes of extreme insulin resistance, in Kahn CR, Weir GC (eds): Joslin's Diabetes Mellitus, ed 13. Baltimore, Williams & Wilkins, 1994, pp 282-299.